Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection.

Authors

Kiran Upadhyay, Children's National Medical Center, Washington, DC
Laurie Midgley, Children's National Medical Center, Washington, DC
Asha Moudgil, George Washington University

Document Type

Journal Article

Publication Date

5-2012

Journal

Pediatric Transplantation

Volume

Volume 16, Issue 3

Inclusive Pages

286-293

Keywords

Antibodies; Monoclonal; Humanized--therapeutic use; Antineoplastic Agents--therapeutic use; Graft Rejection; Kidney Transplantation--methods

APA Citation

Upadhyay, K., Midgley, L., & Moudgil, A. (2012). Safety and efficacy of alemtuzumab in the treatment of late acute renal allograft rejection. Pediatric Transplantation, 16(3), 286-293.

Peer Reviewed

1